AOA 2023: Pooled analysis of Gobi and Mojave studies for NOV03 treatment of MGD
June 23rd 2023Ahmad M. Fahmy, OD, FAAO, Dipl ABO, gives highlights of his AOA 2023 poster that was a pooled analysis of the Gobi and Mojave studies relevant to perfluorohexyloctane (NOV03) for dry eye disease associated with Meibomian gland dysfunction.
AOA 2023: The skinny on intravitreal injections for retinal diseases
June 22nd 2023Over the past decade the progress in retinal disease treatments has exploded with increased numbers of approved pharmaceutical compounds, resulting in more options for treating retinal disease with intravitreal agents and more are in the pipeline.
AOA 2023: Surgical interventions should be considered earlier in glaucoma treatment
June 22nd 2023Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.